Medical-Grade Thermoplastic Polyurethane (TPU) Market latest Statistics on Market Size, Growth, Production, Sales Volume, Sales Price, Market Share and Import vs Export 

Medical-Grade Thermoplastic Polyurethane (TPU) Market Summary Highlights

The global Medical-Grade Thermoplastic Polyurethane (TPU) Market is estimated at approximately USD 1.48 billion in 2026 and is projected to expand at a CAGR of 7.9% through 2032, supported by rising catheter production, growth in wearable medical devices, and higher adoption of biocompatible polymers in minimally invasive procedures. Demand patterns remain heavily concentrated in North America and Western Europe for advanced medical applications, while Asia-Pacific is emerging as a manufacturing and export hub for medical tubing, wound care components, and disposable devices using TPU compounds.

Medical-grade TPU consumption is increasingly tied to long-cycle healthcare trends rather than short-term industrial polymer demand. Aging populations, increasing surgical interventions, expansion of ambulatory care, and stricter material compliance requirements are reshaping procurement strategies among OEMs. Manufacturers are also focusing on phthalate-free, sterilization-resistant, and transparent TPU grades for applications where PVC replacement is accelerating.

Statistical Highlights

• The Medical-Grade Thermoplastic Polyurethane (TPU) Market is forecast to surpass USD 2.35 billion by 2032.
• Polyether-based TPU grades account for nearly 54% of global medical TPU consumption in 2026 due to hydrolysis resistance.
• Catheters and medical tubing contribute approximately 31% of total market revenue.
• Asia-Pacific is expected to record the fastest regional CAGR of 9.1% between 2026 and 2032.
• China, Malaysia, and Costa Rica continue expanding medical device manufacturing exports, increasing TPU resin demand.
• Injection molding applications represent around 42% of processed medical TPU volume globally.
• More than 60% of newly specified TPU grades for healthcare applications are now latex-free and phthalate-free.
• Wearable healthcare devices are projected to increase medical TPU demand by nearly 18% over the next three years.
• Single-use medical device manufacturing capacity globally increased by an estimated 11% during 2025–2026.
• Radiopaque and antimicrobial TPU formulations are witnessing above-average adoption in interventional devices.
• Europe accounts for nearly 27% of high-performance aliphatic medical TPU demand used in advanced skin-contact applications.

In February 2026, Lubrizol Corporation expanded specialty TPU capabilities for medical applications in response to growing demand for wearable healthcare and minimally invasive device materials. The company emphasized medical tubing and skin-contact applications as priority segments.

In October 2025, Covestro AG announced additional investments focused on healthcare-grade thermoplastic elastomer solutions and highlighted sustained demand from catheter and respiratory device manufacturers.

In January 2026, the U.S. Food and Drug Administration introduced updated guidance around material characterization and chemical safety evaluation for medical devices, increasing focus on polymer traceability and extractables testing for medical-grade materials.

Meanwhile, Southeast Asia continued to attract medical manufacturing investments. In March 2026, Malaysia reported additional expansion projects in medical disposables and catheter assembly operations, strengthening regional demand for extrusion-grade TPU materials used in flexible tubing systems.

Expanding Catheter Production Continues to Reshape the Medical-Grade Thermoplastic Polyurethane (TPU) Market

Catheter manufacturing remains one of the strongest demand anchors for medical-grade TPU consumption globally. Hospitals and ambulatory surgical centers are increasing utilization of minimally invasive procedures across cardiovascular, urology, and gastrointestinal applications, directly supporting flexible polymer demand. Compared with conventional elastomers, TPU offers a balance of kink resistance, flexibility, tensile strength, and transparency, making it suitable for multilayer tubing systems and long-duration patient contact.

The transition away from certain PVC-based formulations is becoming more visible in advanced healthcare applications. Regulatory scrutiny around plasticizers and material extractables has encouraged OEMs to evaluate TPU alternatives, particularly in Europe and North America. Polyether TPU grades are gaining traction because of superior microbial resistance and hydrolytic stability, especially in fluid-management systems and long-term implanted device components.

Demand is also benefiting from higher surgical volumes. Elective procedures normalized strongly during 2025 and continued improving in 2026 across major healthcare markets. Increased angioplasty procedures, vascular interventions, and drainage therapies are translating into higher procurement of guidewire jackets, balloon catheter components, and flexible tubing assemblies manufactured using medical TPU compounds.

A parallel trend is visible in neonatal and pediatric care devices, where softer and biocompatible polymers are increasingly prioritized. TPU’s softness range and sterilization compatibility support its use in sensitive applications where repeated flexing and patient comfort are critical.

Wearable Healthcare Devices Increasing TPU Consumption

The integration of electronics into healthcare products is creating new opportunities for the Medical-Grade Thermoplastic Polyurethane (TPU) Market. Flexible wearable sensors, continuous glucose monitoring systems, skin-contact patches, and smart rehabilitation devices increasingly require soft-touch, durable, and sweat-resistant materials.

Medical TPU has become particularly relevant in wearable housings, cable jackets, straps, and breathable films because of its elasticity and abrasion resistance. Unlike rigid plastics, TPU maintains mechanical performance under repeated bending cycles, an important requirement for wearable electronics designed for continuous monitoring.

Healthcare digitization is also supporting demand. Remote patient monitoring installations continue rising across developed healthcare systems as hospitals attempt to reduce inpatient burden and improve chronic disease management. This has expanded production volumes for compact diagnostic and monitoring devices using specialty TPU films and overmolded components.

Manufacturers are investing in thinner and lighter formulations to support miniaturized device architecture. Aliphatic TPU grades are seeing stronger adoption in premium skin-contact applications because of UV resistance and long-term color stability. Although these grades remain more expensive than aromatic TPU, demand continues to increase in advanced wearable medical electronics.

Regulatory Pressure Supporting High-Purity TPU Adoption

One of the defining shifts in the Medical-Grade Thermoplastic Polyurethane (TPU) Market is the increasing emphasis on regulatory compliance, traceability, and biocompatibility documentation. Healthcare OEMs are reducing dependence on commodity polymers and prioritizing suppliers capable of maintaining long-term formulation consistency.

Material suppliers are now expected to provide extensive extractables and leachables data, sterilization validation support, and long-term supply assurance. This trend favors large multinational polymer manufacturers with dedicated healthcare portfolios and controlled manufacturing environments.

Gamma, EtO, and e-beam sterilization compatibility are becoming decisive purchasing factors. Medical device producers increasingly seek TPU formulations capable of maintaining clarity, mechanical integrity, and chemical stability after repeated sterilization exposure. As a result, suppliers are accelerating R&D spending toward high-performance specialty grades rather than commodity elastomers.

Regulatory tightening is also influencing regional sourcing strategies. European MDR implementation continues affecting material qualification timelines, while U.S. regulatory frameworks increasingly emphasize chemical characterization and patient-contact safety documentation. These developments are lengthening qualification cycles but simultaneously increasing barriers for low-cost non-certified suppliers.

Asia-Pacific Becoming a Major Manufacturing Center

Asia-Pacific is no longer only a low-cost production region for healthcare products. The region is strengthening its position as a strategic manufacturing base for advanced medical devices, directly contributing to higher TPU consumption.

China continues expanding domestic medical device production capabilities, particularly in infusion systems, tubing, respiratory products, and wearable diagnostics. Meanwhile, Malaysia and Thailand are attracting investments linked to disposable medical products and export-oriented manufacturing.

India is also witnessing growth in local medical consumables production supported by hospital infrastructure expansion and government-backed healthcare manufacturing initiatives. TPU demand is gradually increasing in tubing, wound dressing films, and diagnostic equipment assemblies manufactured domestically.

Despite regional growth, North America remains the largest innovation center for high-value medical-grade TPU formulations. The United States continues to dominate demand for premium specialty grades used in robotic surgery systems, advanced cardiovascular devices, and long-duration implantable applications.

Material Innovation Shifting Competitive Dynamics

Competition within the Medical-Grade Thermoplastic Polyurethane (TPU) Market is increasingly centered on formulation performance rather than commodity pricing. Manufacturers are differentiating through antimicrobial properties, enhanced chemical resistance, radiopacity, and customized hardness profiles.

Antimicrobial TPU grades are gaining visibility in hospital-contact applications where infection prevention has become a stronger procurement criterion. Similarly, radiopaque TPU materials are being adopted in imaging-guided interventions to improve device visibility during procedures.

Sustainability discussions are also influencing product development. Several polymer producers are exploring bio-attributed feedstocks and lower-emission TPU manufacturing processes for healthcare applications, although adoption remains at an early stage because regulatory approvals for material changes can be time-intensive.

At the same time, supply chain resilience has become a critical procurement consideration following disruptions experienced in medical manufacturing over recent years. Healthcare OEMs are increasingly qualifying multiple TPU suppliers and maintaining regional inventory buffers for essential device components.

Regional Demand Patterns in the Medical-Grade Thermoplastic Polyurethane (TPU) Market

North America continues to command the largest share of the Medical-Grade Thermoplastic Polyurethane (TPU) Market, supported by high-value medical device manufacturing, strong hospital spending, and sustained investment in minimally invasive technologies. The United States alone accounts for a substantial portion of global interventional catheter production, particularly for cardiovascular and electrophysiology procedures where TPU-based tubing and balloon materials are extensively used.

The U.S. Centers for Medicare & Medicaid Services projected national healthcare expenditure growth above 5% annually through 2030, creating long-term procurement support for advanced medical polymers. Higher procedural volumes directly influence demand for extrusion-grade and injection-molding-grade TPU compounds used in respiratory systems, vascular access devices, and wearable healthcare products.

Demand in Europe remains concentrated in Germany, Ireland, Switzerland, and France, where medical device exports continue expanding. Germany’s medical technology industry association BVMed reported continued growth in diagnostic and surgical device manufacturing entering 2026, supporting specialty polymer consumption. European manufacturers are increasingly specifying biocompatible and phthalate-free materials because of stricter regulatory compliance under MDR frameworks.

Ireland has emerged as a particularly important production center due to the concentration of multinational medical device facilities. Catheter systems, infusion components, and minimally invasive surgical devices manufactured in the country continue driving regional TPU demand. TPU suppliers with validated healthcare-grade portfolios are benefiting from long-term procurement contracts in this ecosystem.

Asia-Pacific is recording the fastest consumption growth in the Medical-Grade Thermoplastic Polyurethane (TPU) Market, led by China, Japan, South Korea, Malaysia, and India. China’s domestic medical device industry has expanded rapidly following healthcare infrastructure upgrades and localized manufacturing incentives. TPU demand in the country is increasingly linked to infusion therapy products, dialysis tubing, wound-care materials, and wearable healthcare electronics.

Japan maintains stable demand for high-purity medical elastomers used in advanced healthcare applications, particularly precision tubing and implant-adjacent components. South Korea’s expansion in diagnostic devices and wearable biosensors is also increasing consumption of soft-touch TPU films and specialty compounds.

India is showing strong momentum in disposable medical products and hospital consumables. Government initiatives promoting domestic medical device manufacturing, alongside rising private hospital investments, are increasing regional consumption of medical polymers. Flexible tubing systems, blood management products, and oxygen therapy devices represent emerging application areas for medical TPU compounds across Indian manufacturing clusters.

Latin America and the Middle East remain comparatively smaller markets, although import dependence on medical devices continues supporting moderate TPU demand growth. Brazil and Mexico are witnessing rising healthcare investments and localized assembly operations for consumables and diagnostic devices.

Segmentation Highlights

• Polyether TPU grades account for the dominant market share due to hydrolysis resistance and microbial stability.
• Catheters and medical tubing remain the leading application segment with more than 30% revenue contribution.
• Injection molding is the largest processing segment, followed by extrusion for tubing applications.
• Wearable medical devices represent one of the fastest-growing end-use categories through 2032.
• Aromatic TPU grades continue dominating cost-sensitive applications, while aliphatic TPU demand is increasing in premium skin-contact devices.
• North America leads in revenue generation, while Asia-Pacific records the highest volume growth.
• Disposable medical products are generating accelerated demand for flexible TPU films and elastomeric seals.
• Antimicrobial and radiopaque TPU compounds are witnessing above-average adoption in interventional healthcare devices.

Medical-Grade Thermoplastic Polyurethane (TPU) Production Expanding Across Asia

Global manufacturing capacity additions are reshaping the supply structure of healthcare elastomers. Medical-Grade Thermoplastic Polyurethane (TPU) production is increasingly shifting toward Asia-Pacific because of lower processing costs, expanding medical device exports, and integrated chemical manufacturing infrastructure.

China has significantly increased specialty polymer output over the last three years, including healthcare-grade TPU materials used in tubing and molded components. Local compounders are scaling up capabilities to reduce dependence on imported medical elastomers. However, high-end implant-grade and long-term biostable TPU formulations continue to be dominated by multinational producers in the United States and Europe.

Malaysia and Singapore are also strengthening their role in Medical-Grade Thermoplastic Polyurethane (TPU) production linked to the region’s growing medical glove, catheter, and disposable healthcare device ecosystem. Southeast Asian production facilities are increasingly aligned with export-oriented medical manufacturing standards, including ISO 10993 compliance and sterilization compatibility requirements.

In North America, TPU manufacturers are prioritizing high-margin specialty grades instead of commodity-scale expansion. Several suppliers are investing in dedicated healthcare production lines with controlled contamination environments to support traceability requirements from medical OEMs.

By 2026, global Medical-Grade Thermoplastic Polyurethane (TPU) production capacity is estimated to exceed 420 kilotons annually, with Asia-Pacific accounting for nearly 46% of total installed capability. Capacity utilization rates remain relatively stable because healthcare demand is less cyclical than industrial TPU applications.

Application Segmentation Becoming More Specialized

The Medical-Grade Thermoplastic Polyurethane (TPU) Market is no longer concentrated only around traditional tubing applications. Product differentiation in healthcare devices is expanding the material’s role across wearable systems, implant-assistive components, and soft diagnostic equipment.

Medical tubing continues to dominate demand because of TPU’s balance between flexibility and burst resistance. Multi-layer co-extruded tubing systems increasingly utilize TPU in drug delivery systems and minimally invasive surgical equipment.

Wound-care applications are gaining importance, particularly breathable TPU films used in transparent dressings and adhesive healthcare patches. Rising chronic wound prevalence and increasing diabetic patient populations are supporting growth in advanced wound management products globally.

Wearable healthcare systems are another rapidly expanding segment. Continuous glucose monitoring patches, smart rehabilitation devices, and biosensor-integrated wearables increasingly rely on TPU because of elasticity and skin-contact performance. The International Diabetes Federation estimated that global diabetes prevalence continues increasing steadily into 2026, indirectly strengthening demand for wearable monitoring technologies using TPU-based flexible components.

Respiratory healthcare products are also contributing to market expansion. Demand for oxygen therapy devices, respiratory masks, and ventilator tubing remains structurally elevated compared with pre-2020 levels, supporting ongoing procurement of medical elastomers.

Medical-Grade Thermoplastic Polyurethane (TPU) Price Trend Reflects Raw Material Volatility

The Medical-Grade Thermoplastic Polyurethane (TPU) Price Trend during 2025–2026 has remained moderately volatile because of fluctuations in feedstock costs, particularly MDI and polyol inputs. Supply-demand balance in upstream petrochemicals continues influencing pricing strategies among medical TPU suppliers.

Average Medical-Grade Thermoplastic Polyurethane (TPU) Price levels in North America remained comparatively higher than Asia because of stricter compliance requirements, higher energy costs, and premium pricing for validated healthcare-grade materials. Specialty aliphatic TPU grades used in wearable and skin-contact applications command significantly higher margins than conventional aromatic TPU products.

In Europe, energy market instability and environmental compliance costs influenced the Medical-Grade Thermoplastic Polyurethane (TPU) Price Trend throughout late 2025 and early 2026. Manufacturers passed part of the increased operational expenses downstream to medical device OEMs, particularly for high-purity extrusion grades.

Asian markets experienced comparatively balanced pricing conditions because of expanded local production capacity and stronger competition among regional suppliers. However, high-end imported medical TPU grades continued maintaining premium pricing because of qualification barriers and limited supplier availability.

The Medical-Grade Thermoplastic Polyurethane (TPU) Price for extrusion-grade compounds used in catheters and fluid-management systems remained relatively resilient even during broader industrial polymer slowdowns. Healthcare applications typically operate under long-term qualification cycles, limiting rapid supplier substitution and reducing short-term pricing pressure.

Another important factor shaping the Medical-Grade Thermoplastic Polyurethane (TPU) Price Trend is the growing preference for customized formulations. Medical OEMs increasingly require specific hardness ranges, sterilization compatibility, and antimicrobial functionality, which raises compounding complexity and increases average selling prices.

Freight normalization after earlier global logistics disruptions has improved supply consistency, although regional inventory strategies remain conservative. Many medical device producers continue maintaining higher safety stock levels for critical TPU materials, especially for life-supporting and high-volume disposable applications.

The premiumization of healthcare polymers is expected to continue through 2030 as regulatory scrutiny intensifies and advanced medical device applications require more specialized material performance.

Leading Manufacturers in the Medical-Grade Thermoplastic Polyurethane (TPU) Market

The competitive environment of the Medical-Grade Thermoplastic Polyurethane (TPU) Market is characterized by the presence of a limited number of multinational specialty polymer manufacturers with strong regulatory compliance capabilities and established healthcare-grade product portfolios. Medical TPU production requires highly controlled manufacturing environments, long-term biocompatibility validation, sterilization testing, and formulation consistency, which continue to create significant entry barriers for smaller suppliers.

The market remains moderately consolidated, with Lubrizol, Covestro, BASF, Huntsman, Wanhua Chemical, Teknor Apex, and Avient accounting for a substantial share of global revenue. Premium implantable TPU materials and long-term patient-contact applications remain concentrated among companies with dedicated healthcare R&D infrastructure and extensive regulatory documentation support.

Competition in the Medical-Grade Thermoplastic Polyurethane (TPU) Market is increasingly focused on material performance rather than pricing alone. Manufacturers are investing in hydrolysis-resistant grades, antimicrobial formulations, radiopaque compounds, and advanced wearable-device TPU films to strengthen differentiation across medical applications.

Lubrizol Maintains Strong Presence in High-Value Medical Applications

Lubrizol remains one of the most prominent participants in the Medical-Grade Thermoplastic Polyurethane (TPU) industry, particularly in catheter systems, minimally invasive devices, and implantable applications. Its ESTANE® TPU and Tolerathane™ TPU product families are widely used in cardiovascular devices, neurovascular catheters, drug-delivery systems, and structural heart applications.

The company continues expanding medical manufacturing capabilities to strengthen integration between polymer supply and medical device production. Lubrizol has increased investments in precision extrusion and catheter component manufacturing, particularly in Asia-Pacific, where medical device exports continue growing rapidly.

Its TPU materials are valued for flexibility, kink resistance, sterilization compatibility, and oxidative stability. These characteristics are especially important in long-duration implantable devices and advanced interventional procedures where material reliability directly affects device performance.

Lubrizol is estimated to account for nearly one-fifth of global premium medical TPU demand, particularly within cardiovascular and implantable device applications.

Covestro Expanding Wearable Healthcare and Medical Film Portfolio

Covestro continues strengthening its position in the Medical-Grade Thermoplastic Polyurethane (TPU) Market through its Texin® Rx, Desmopan® Rx, and Platilon® product lines. The company maintains strong exposure to medical tubing, breathable healthcare films, wound-care systems, and wearable healthcare devices.

The company’s TPU films are increasingly utilized in continuous glucose monitoring systems, ECG monitoring patches, and flexible wearable healthcare electronics because of high elasticity, transparency, and skin-contact compatibility. Demand for these products is increasing alongside growth in remote patient monitoring and digital healthcare systems.

Covestro has also focused on regional supply expansion across Asia-Pacific to support growing healthcare manufacturing demand in China, Malaysia, and Southeast Asia. Localized production strategies are helping reduce lead times for medical device manufacturers while improving supply chain stability.

The company remains particularly strong in premium aliphatic TPU grades used in skin-contact and UV-resistant healthcare applications.

BASF and Huntsman Focus on Medical Extrusion and Injection Molding Applications

BASF participates in the Medical-Grade Thermoplastic Polyurethane (TPU) Market through its Elastollan® TPU portfolio. The company benefits from large-scale feedstock integration and diversified polyurethane manufacturing infrastructure.

Its healthcare-grade TPU materials are widely used in extrusion and injection molding applications, including medical tubing, soft-touch equipment housings, seals, and fluid-management systems. BASF continues emphasizing sterilization-resistant and hydrolysis-stable formulations for healthcare environments requiring long-term material durability.

Huntsman Corporation maintains an important position through its IROGRAN® TPU portfolio. The company supplies TPU materials for flexible medical components, tubing systems, and transparent molded healthcare devices where abrasion resistance and elasticity are critical.

Although BASF and Huntsman maintain strong global distribution capabilities, their exposure remains comparatively higher in mid-range and industrial-adjacent medical TPU applications rather than highly specialized implantable segments.

Asian Manufacturers Increasing Market Penetration

Asian manufacturers are steadily increasing their presence in the Medical-Grade Thermoplastic Polyurethane (TPU) industry as regional medical device manufacturing capacity expands. Wanhua Chemical has emerged as one of the most notable participants, supported by integrated isocyanate production and cost competitiveness.

China’s healthcare manufacturing expansion has strengthened demand for domestically produced TPU compounds used in infusion systems, respiratory devices, disposable medical products, and tubing applications. Local suppliers are improving production quality and regulatory compliance capabilities to reduce dependence on imported healthcare elastomers.

Despite this progress, multinational suppliers continue dominating high-end implantable TPU applications because of longer regulatory qualification histories and stronger technical support capabilities.

Teknor Apex remains active in customized healthcare elastomer compounding, supplying specialized TPU formulations for tubing, overmolded medical housings, and flexible patient-contact applications. Avient Corporation is also expanding healthcare-focused polymer solutions tailored for sterilization compatibility and color stability.

Medical-Grade Thermoplastic Polyurethane (TPU) Market Share by Manufacturers

The Medical-Grade Thermoplastic Polyurethane (TPU) Market demonstrates a concentrated competitive structure in premium applications, although broader healthcare TPU categories remain more fragmented.

Lubrizol and Covestro collectively account for a major share of global premium medical TPU consumption, particularly in catheter systems, implantable devices, and advanced wearable healthcare products. BASF and Huntsman maintain significant participation in extrusion-grade and injection-molding-grade TPU materials, while Asian suppliers continue expanding share in disposable and cost-sensitive healthcare products.

North American and European manufacturers continue controlling a substantial portion of high-margin healthcare TPU applications because of stronger regulatory infrastructure, long-term medical OEM partnerships, and advanced formulation capabilities.

Asian producers are gaining momentum in volume-driven applications linked to medical consumables, respiratory products, and flexible tubing systems. This shift is gradually changing global supply dynamics, especially in Asia-Pacific where localized healthcare manufacturing is expanding rapidly.

Product Line Innovation Reshaping Competition

Competition within the Medical-Grade Thermoplastic Polyurethane (TPU) Market is becoming increasingly specialized as medical device manufacturers seek application-specific material solutions.

Key product families influencing competitive positioning include:

• ESTANE® TPU for catheter systems and flexible medical tubing
• Tolerathane™ TPU for implantable and biostable medical applications
• Texin® Rx for medical injection molding and extrusion applications
• Desmopan® Rx for healthcare tubing and wearable systems
• Platilon® TPU films for medical wearables and skin-contact devices
• Elastollan® medical TPU grades for fluid-management and molded healthcare components
• IROGRAN® TPU materials for transparent and flexible medical devices

Manufacturers are increasingly developing TPU grades with enhanced softness, antimicrobial protection, radiopacity, hydrolysis resistance, and sterilization durability. Product customization is becoming a major competitive factor as healthcare OEMs demand tighter performance specifications for advanced medical applications.

Recent Industry Developments and Strategic Expansion

In early 2026, several leading manufacturers expanded investments focused on implantable and wearable healthcare TPU materials. Companies prioritized advanced extrusion systems, healthcare-grade film technologies, and localized manufacturing capabilities to support rising demand from catheter and wearable medical device producers.

Lubrizol strengthened its medical device manufacturing footprint in Asia with additional investments targeting neurovascular and cardiovascular tubing applications. The company also introduced new implantable TPU formulations focused on long-term oxidative stability and flexibility.

Covestro continued expanding healthcare-grade TPU film capabilities for wearable medical devices, transparent dressings, and skin-contact applications. The company also increased regional TPU production support in Asia-Pacific to improve supply responsiveness for medical OEMs.

Asian TPU suppliers accelerated investments in medical compounding capacity during 2025–2026 as regional healthcare manufacturing expanded across China, Malaysia, and India. Localized production is becoming increasingly important for disposable healthcare products and tubing systems.

The industry is also witnessing stronger collaboration between polymer manufacturers and medical device OEMs to develop customized TPU formulations optimized for minimally invasive surgery, wearable diagnostics, and next-generation patient monitoring systems.